ArticleCureus2025
Fluorescence-Guided Bladder and Ureter Visualization in Benign Robotic Gynecologic Surgery: A Series of Five Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indocyanine green (ICG) near-infrared fluorescence imaging is well established in gynecologic oncology, but its role in benign minimally invasive surgery is still limited and not standardized. Increasing cesarean section and endometriosis rates elevate the risk of urinary tract injury, highlighting the need for improved intraoperative visualization. This case series evaluates the practical use and reliability of ICG fluorescence for bladder and ureteral identification during benign robotic gynecologic procedures. Two patients undergoing robotic hysterectomy using the Da Vinci Xi Firefly system (Intuitive Surgical, Sunnyvale, California, United States) for benign indications had a history of prior cesarean deliveries. Intravesical ICG was administered to delineate the bladder. However, fluorescence was patchy and unreliable, with only partial bladder wall visualization despite adequate technique. In contrast, two patients with deep infiltrating endometriosis involving the ureter underwent cystoscopic retrograde instillation of ICG, which provided consistent and clear fluorescence-guided ureteral mapping, facilitating safe dissection and preservation. A fifth case involved a patient with symptomatic adenomyosis and an endometriotic ovarian cyst, in whom preoperative imaging also revealed an ectopic left kidney, requiring careful retroperitoneal assessment and ureteral identification during robotic hysterectomy. All surgeries were completed robotically without complications. Ureteral visualization with ICG was reproducible and effective, while bladder demarcation using intravesical ICG showed variable fluorescence, likely due to fibrosis and impaired diffusion in scarred tissue. Fluorescence-guided robotic surgery using ICG is a valuable adjunct for ureteral identification in benign gynecology, particularly in advanced endometriosis. However, its application for bladder demarcation after multiple cesarean sections appears less reliable, showing the need for protocol improvement and further evaluation before routine use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.